Veltex logo

Veltex(OTC) VLXC

Market Cap$4.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1991)-100%
5 Year-95%
1 Year-46%
1 Month-3%
$0.04
+31.69%
+0.01Today
Veltex last closing stock price
MetricPriceDate
Last closeUSD 0.042026-10-20
Veltex stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.33%USD 0.042026-10-13
1 month-2.73%USD 0.042026-09-17
3 month+42.67%USD 0.032026-07-21
Year to date-37.97%USD 0.072025-12-29
1 year-45.82%USD 0.082025-10-16
3 year-73.33%USD 0.162023-10-19
5 year-95.19%USD 0.892021-10-21
Since inception-100%USD 27,777.781991-01-02

Veltex Financials at a Glance

Market Cap

$4.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.52M

Net Income (TTM)

-$1.64M

EPS (TTM)

-$0.02

P/E Ratio

-2.56

Dividend

$0.00

Beta (Volatility)

0.28 (Low)

Price

$0.04

Volume

100

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.03 - $0.08

Estimated Earnings Date

N/A

VLXC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Veltex

Veltex Corporation is focused on creating and acquiring businesses that deliver solutions in the health, wellness, and recovery sectors. Established in 1987 and headquartered in Chicago, Illinois, the company primarily serves rehabilitation and treatment centers.

Products and Services
  • Health and wellness solutions for rehabilitation centers
  • Acquisition of businesses in the recovery sector
  • Innovative services tailored to treatment facilities
Growth Outlook
  • Recent quarterly revenue increased to $310,810, showing positive momentum
  • Gross profit margin improved to 90.2% in Q2 2026
  • Focus on expanding service offerings to capture market share
Financial Highlights
  • Trailing twelve months (TTM) revenue of $1,305,000 reflects growth potential
  • Operating income for Q2 2026 was -$143,071, indicating ongoing investment in growth
  • Cash and cash equivalents increased to $5,769 in Q2 2026
Veltex Corporation operates in the healthcare sector, specifically within medical care facilities. The company has shown resilience despite challenges, with a notable increase in revenue and gross profit margins in recent quarters. The focus on health and wellness solutions positions Veltex to capitalize on the growing demand for rehabilitation services. The financial data indicates a commitment to growth, with significant investments in expanding service offerings. As the company continues to navigate the healthcare landscape, its strategic initiatives may enhance its market presence and financial performance.
AI Generated • Oct 5, 2026

Industry

Healthcare Providers and Services

CEO

Andreas Mauritzson

Headquarters

Chicago, IL 60602, US

VLXC Financials

Key Financial Metrics (TTM)

Gross Margin

67.11%

Operating Margin

-86.73%

Net Income Margin

-108.02%

Return on Equity

56.80%

Return on Capital

-453.08%

Return on Assets

-90.28%

Earnings Yield

-39.06%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

101.37M

Volume

100

Avg. Volume

2.21K

Financials (TTM)

Gross Profit

$1.02M

Operating Income

-$1.32M

EBITDA

-$1.15M

Operating Cash Flow

-$683.88K

Capital Expenditure

-$5.00

Free Cash Flow

-$683.88K

Cash & ST Invst.

$5.77K

Total Debt

$3.58M

Veltex Performance Analysis

Veltex annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 30,810692.4%
20232023-12-31USD 838,6542622.0%
20242024-12-31USD 1,381,25864.7%
20252025-12-31USD 1,905,18537.9%
Veltex sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3010.4%
Q42025-12-31-17.9%
Q12026-03-31-29.9%
Q22026-06-307.1%
Veltex annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.0518.5%
20232023-12-31USD -0.01-73.9%
20242024-12-31USD -0.01-9.3%
20252025-12-31USD -0.0113.7%
Veltex sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3029.6%
Q42025-12-31-278.9%
Q12026-03-3133.3%
Q22026-06-3041.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$310.81K

-31.9%

Gross Profit

$280.39K

-35.6%

Gross Margin

90.21%

N/A

Market Cap

$4.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.62K

N/A

Employees

1,200

N/A

Net Income

-$277.89K

-13.5%

EBITDA

-$112.65K

-10.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$5.77K

-78.5%

Total Debt

$3.58M

+23.6%

Accounts Receivable

$959.63K

+5.9%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$3.58M

+23.6%

Return on Assets

-90.28%

N/A

Return on Invested Capital

41.50%

N/A

Free Cash Flow

-$123.99K

-31.3%

Operating Cash Flow

-$123.99K

-39.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PMEDFQscreen Ai Inc.
$0.02+0.00%
ADMTADM Tronics Unlimited, Inc.
$0.05+0.00%
BVAXFBioVaxys Technology Corp.
$0.09+9.09%
BICXBioCorRx Inc.
$0.21+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$147.49+1.89%
TAT&T
$20.93-7.96%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$83.56+1.77%
NUNu Holdings
$15.16+2.92%

Questions About VLXC

What is the current price of Veltex?

Veltex is trading at $0.04 per share.

What is the 52-week range for Veltex?

Over the past 52 weeks, Veltex has traded between $0.03 and $0.08.

How much debt does Veltex have?

As of the most recent reporting period, Veltex reported total debt of $3.58M.

How much cash does Veltex have on hand?

Veltex reported $5.77K in cash and cash equivalents in its most recent financial results.

What is Veltex’s dividend yield?

Veltex does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.